Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 158,313Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Interquim, SA

02 1MSN Laboratories Private Limited

03 1Polaris AI Pharma Co., Ltd.

04 1Siegfried Evionnaz SA_x000D_ @[Undifferentiated Process] Jetpharma SA

05 1Takeda GmbH, Production site Singen

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
The Generic Rx Session
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInterquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Roflumilast

Registrant Name : Seongi Bio Co., Ltd.

Registration Date : 2016-12-29

Registration Number : Su259-4-ND

Manufacturer Name : Interquim, SA

Manufacturer Address : Joan Buscalla 10, E-08173 Sant Cugat del Valles, Barcelona, ​​Spain

Interquim

02

The Generic Rx Session
Not Confirmed
arrow
arrow
The Generic Rx Session
Not Confirmed

Roflumilast

Registrant Name : Pharmapia Co., Ltd.

Registration Date : 2017-04-03

Registration Number : Su258-2-ND

Manufacturer Name : MSN Laboratories Private Lim...

Manufacturer Address : Sy. No. 317, 320, 321, 322, 323, 604 & 605, Rudraram (Village), Patancheru (Mandal), ...

blank

03

The Generic Rx Session
Not Confirmed
arrow
arrow
The Generic Rx Session
Not Confirmed

Roflumilast

Registrant Name : AstraZeneca Korea Ltd.

Registration Date : 2014-09-17

Registration Number : Su5550-4-ND

Manufacturer Name : Siegfried Evionnaz SA_x000D_...

Manufacturer Address : Route du Simplon 1, 36, 1902 Evionnaz, Switzerland_x000D_ @[Pulverization Process] Vi...

blank

04

The Generic Rx Session
Not Confirmed
arrow
arrow
The Generic Rx Session
Not Confirmed

Roflumilast

Registrant Name : AstraZeneca Korea Ltd.

Registration Date : 2011-04-29

Registration Number : Su5550-1-ND

Manufacturer Name : Takeda GmbH, Production site...

Manufacturer Address : Robert-Bosch-Strass 8 78224 Singen Germany

blank

05

The Generic Rx Session
Not Confirmed
arrow

arrow
The Generic Rx Session
Not Confirmed

Roflumilast

Registrant Name : Polaris AI Pharma Co., Ltd.

Registration Date : 2024-11-29

Registration Number : 1962-9-ND

Manufacturer Name : Polaris AI Pharma Co., Ltd.

Manufacturer Address : 25 Balan Industrial Complex-ro, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, 34 Block 10-1...

blank

Looking for 162401-32-3 / Roflumilast API manufacturers, exporters & distributors?

Roflumilast manufacturers, exporters & distributors 1

48

PharmaCompass offers a list of Roflumilast API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Roflumilast manufacturer or Roflumilast supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Roflumilast manufacturer or Roflumilast supplier.

PharmaCompass also assists you with knowing the Roflumilast API Price utilized in the formulation of products. Roflumilast API Price is not always fixed or binding as the Roflumilast Price is obtained through a variety of data sources. The Roflumilast Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Roflumilast

Synonyms

162401-32-3, Daxas, 3-(cyclopropylmethoxy)-n-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide, Daliresp, By217, Byk20869

Cas Number

162401-32-3

Unique Ingredient Identifier (UNII)

0P6C6ZOP5U

About Roflumilast

Roflumilast is an orally available, long-acting inhibitor of phosphodiesterase (PDE) type 4 (PDE4), with anti-inflammatory and potential antineoplastic activities. Upon administration, roflumilast and its active metabolite roflumilast N-oxide selectively and competitively bind to and inhibit PDE4, which leads to an increase of both intracellular levels of cyclic-3',5'-adenosine monophosphate (cAMP) and cAMP-mediated signaling. cAMP prevents phosphorylation of spleen tyrosine kinase (SYK) and abrogates activation of the PI3K/AKT/mTOR signaling pathway, which may result in the induction of apoptosis. PDE4, a member of the PDE superfamily that hydrolyses cAMP and 3',5'-cyclic guanosine monophosphate (cGMP) to their inactive 5' monophosphates, is upregulated in a variety of cancers and may contribute to chemoresistance; it also plays a key role in inflammation, especially in inflammatory airway diseases.

Roflumilast Manufacturers

A Roflumilast manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Roflumilast, including repackagers and relabelers. The FDA regulates Roflumilast manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Roflumilast API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Roflumilast manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Roflumilast Suppliers

A Roflumilast supplier is an individual or a company that provides Roflumilast active pharmaceutical ingredient (API) or Roflumilast finished formulations upon request. The Roflumilast suppliers may include Roflumilast API manufacturers, exporters, distributors and traders.

click here to find a list of Roflumilast suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Roflumilast KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Roflumilast Drug Master File in Korea (Roflumilast KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Roflumilast. The MFDS reviews the Roflumilast KDMF as part of the drug registration process and uses the information provided in the Roflumilast KDMF to evaluate the safety and efficacy of the drug.

After submitting a Roflumilast KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Roflumilast API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Roflumilast suppliers with KDMF on PharmaCompass.

Roflumilast Manufacturers | Traders | Suppliers

Roflumilast Manufacturers, Traders, Suppliers 1
20

We have 4 companies offering Roflumilast

Get in contact with the supplier of your choice:

  1. Interquim SA
  2. MSN Laboratories
  3. Siegfried AG
  4. Takeda Pharmaceutical
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.